関節リウマチ（RA）治療におけるトゥリソキバート（MK-7240）の臨床試験（MK-7240-014）

基本情報

NCT ID

NCT07176390

ステータス

募集中

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

182

治験依頼者名

Merck Sharp & Dohme LLC

概要

Researchers are looking for new ways to treat rheumatoid arthritis (RA). Methotrexate (MTX) is a standard (usual) treatment for RA. However, MTX and other current treatments may not work well to treat RA symptoms for many people. This study will help find out if a study medicine called tulisokibart can treat symptoms of active RA in people who are taking MTX. In this study, researchers will look at different doses of tulisokibart. Researchers want to learn if at least one of the study doses of tulisokibart works better than a placebo to lessen RA symptoms. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of the study medicine.

対象疾患

介入

依頼者（Sponsor）

実施施設 (8)